MBGRON-S 50-5

MRP
565/-

Description
Each film-coated tablet contains: Mirabegron IP 50 mg (as extended release) + Solifenacin Succinate IP 5 mg. Excipients q.s.

Doses
As directed by the physician.

Indication
Mirabegron + Solifenacin is used in the treatment of Overactive Bladder (OAB) symptoms. This combination of two medicines works together: Mirabegron, a beta-3 receptor agonist, activates receptors in the bladder, causing the bladder muscles to relax, while Solifenacin helps manage symptoms like frequent or urgent urination and incontinence.